These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 15039508)

  • 41. Comparison of gut-directed hypnotherapy and unspecific hypnotherapy as self-help format in children and adolescents with functional abdominal pain or irritable bowel syndrome: a randomized pilot study.
    Gulewitsch MD; Schlarb AA
    Eur J Gastroenterol Hepatol; 2017 Dec; 29(12):1351-1360. PubMed ID: 29023318
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Systematic review: the effectiveness of hypnotherapy in the management of irritable bowel syndrome.
    Wilson S; Maddison T; Roberts L; Greenfield S; Singh S;
    Aliment Pharmacol Ther; 2006 Sep; 24(5):769-80. PubMed ID: 16918880
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hypnotherapy for irritable bowel syndrome: an audit of one thousand adult patients.
    Miller V; Carruthers HR; Morris J; Hasan SS; Archbold S; Whorwell PJ
    Aliment Pharmacol Ther; 2015 May; 41(9):844-55. PubMed ID: 25736234
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Attenuation of the colorectal tonic reflex in female patients with irritable bowel syndrome.
    Ng C; Danta M; Kellow J; Badcock CA; Hansen R; Malcolm A
    Am J Physiol Gastrointest Liver Physiol; 2005 Sep; 289(3):G489-94. PubMed ID: 15905412
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hypnosis Treatment of Gastrointestinal Disorders: A Comprehensive Review of the Empirical Evidence.
    Palsson OS
    Am J Clin Hypn; 2015 Oct; 58(2):134-58. PubMed ID: 26264539
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Functional dyspepsia and irritable bowel syndrome: is there a common pathophysiological basis?
    Holtmann G; Goebell H; Talley NJ
    Am J Gastroenterol; 1997 Jun; 92(6):954-9. PubMed ID: 9177509
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Long-term success of GUT-directed group hypnosis for patients with refractory irritable bowel syndrome: a randomized controlled trial.
    Moser G; Trägner S; Gajowniczek EE; Mikulits A; Michalski M; Kazemi-Shirazi L; Kulnigg-Dabsch S; Führer M; Ponocny-Seliger E; Dejaco C; Miehsler W
    Am J Gastroenterol; 2013 Apr; 108(4):602-9. PubMed ID: 23419384
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hypnotherapy for persons with Irritable Bowel Syndrome: A three-arm randomized controlled trial.
    Wan YP; Ng SM
    Am J Clin Hypn; 2022 Oct; 65(2):110-135. PubMed ID: 35412965
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pilot-RCT of an integrative group therapy for patients with refractory irritable bowel syndrome (ISRCTN02977330).
    Berens S; Stroe-Kunold E; Kraus F; Tesarz J; Gauss A; Niesler B; Herzog W; Schaefert R
    J Psychosom Res; 2018 Feb; 105():72-79. PubMed ID: 29332637
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Is the irritable bowel really irritable?
    Coremans G; Tack J; Vantrappen G; Janssens J; Annese V
    Ital J Gastroenterol; 1991 Nov; 23(8 Suppl 1):39-40. PubMed ID: 1756281
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Long-term follow-up of gut-directed hypnotherapy vs. standard care in children with functional abdominal pain or irritable bowel syndrome.
    Vlieger AM; Rutten JM; Govers AM; Frankenhuis C; Benninga MA
    Am J Gastroenterol; 2012 Apr; 107(4):627-31. PubMed ID: 22310221
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Nurse-led hypnotherapy: an innovative approach to Irritable Bowel Syndrome.
    Bremner H
    Complement Ther Clin Pract; 2013 Aug; 19(3):147-52. PubMed ID: 23890461
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Practitioners' experiences of using Gut Directed Hypnosis for irritable bowel syndrome: Perceived impact upon client wellbeing: A qualitative study.
    Pemberton L; Kita L; Andrews K
    Complement Ther Med; 2020 Dec; 55():102605. PubMed ID: 33220622
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Long term benefits of hypnotherapy for irritable bowel syndrome.
    Gonsalkorale WM; Miller V; Afzal A; Whorwell PJ
    Gut; 2003 Nov; 52(11):1623-9. PubMed ID: 14570733
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of cholecystokinin on rectal motor and sensory function in patients with irritable bowel syndrome and healthy controls.
    van der Schaar PJ; van Hoboken E; Ludidi S; Masclee AA
    Colorectal Dis; 2013 Jan; 15(1):e29-34. PubMed ID: 23006632
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The mind-body connection in irritable bowel syndrome: A randomised controlled trial of hypnotherapy as a treatment.
    Phillips-Moore JS; Talley NJ; Jones MP
    Health Psychol Open; 2015 Jan; 2(1):2055102914564583. PubMed ID: 28070348
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Motility disorders in the irritable bowel syndrome.
    Lind CD
    Gastroenterol Clin North Am; 1991 Jun; 20(2):279-95. PubMed ID: 2066153
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Systematic review, meta-analysis with subgroup analysis of hypnotherapy for irritable bowel syndrome, effect of intervention characteristics.
    Krouwel M; Farley A; Greenfield S; Ismail T; Jolly K
    Complement Ther Med; 2021 Mar; 57():102672. PubMed ID: 33508441
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Distension technique influences the relationship between colonic and rectal hypersensitivity in irritable bowel syndrome.
    Ng C; Malcolm A; Hansen R; Kellow JE
    Neurogastroenterol Motil; 2006 Mar; 18(3):206-10. PubMed ID: 16487411
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Where does hypnotherapy stand in the management of irritable bowel syndrome? A systematic review.
    Gholamrezaei A; Ardestani SK; Emami MH
    J Altern Complement Med; 2006; 12(6):517-27. PubMed ID: 16884342
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.